Celularity (CELU) Gets a Buy From H.C. Wainwright
Analysts' Opinions Are Mixed on These Services Stocks: Celularity (CELU) and Madison Square Garden Entertainment (MSGE)
HC Wainwright Lowers Price Target on Celularity to $2.50 From $15, Maintains Buy Rating
Celularity Analyst Ratings
H.C. Wainwright Sticks to Its Buy Rating for Celularity (CELU)
Celularity Analyst Ratings
Oppenheimer Adjusts Celularity Price Target to $6 From $8, Maintains Outperform Rating